Transcriptome analysis of human acute myeloid leukemia cell line MV4-11
We aimed to investigate the effects of the combined treatment with anti-tumor compound (R)-WAC-224 and anti-Bcl2 agent Venetoclax in human acute myeloid leukemia cell line MV4-11. We performed transcriptome analysis in MV4-11 cells treated with (R)-WAC-224 and/or Venetoclax.